{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-014573","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2024-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.166949+00:00","generated_at":"2026-06-04T02:55:24.862192+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Oncology Institute issues FY2023 results slide presentation; no specific figures in filing excerpt","bullets":["Presentation covers financial results for Q4 and full year ended Dec 31, 2023.","Company also provided business updates and guidance for the year ending Dec 31, 2023.","No quantitative data (revenue, EPS, etc.) appears in the provided excerpt of Exhibit 99.1.","Investors should review the full slide deck for actual performance metrics.","Filing date April 3, 2024; tickers TOI and TOIIW."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-014573","json":"https://secwatch.observer/filing/0001628280-24-014573.json","markdown":"https://secwatch.observer/filing/0001628280-24-014573.md","text":"https://secwatch.observer/filing/0001628280-24-014573.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/0001628280-24-014573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/toi-20240403.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:55:24.862192+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"10e30d1ab9d721ea4fbd356b78204a5d4dab8bfc","claim":"Oncology Institute, Inc. reported financial results for the three months and year ended December 31, 2023.","evidence_excerpt":"On April 3, 2024, The Oncology Institute, Inc. (the \"Company\") issued a slide presentation which includes the Company's financial results for the three months and year ended December 31, 2023 and certain other financial information.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/0001628280-24-014573-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months and year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}